Senior insider sale
SVP, Chief Development Officer at MERSANA THERAPEUTICS, INC. — senior position signals high conviction
$27.6K
13.69K shares
What this filing means
BALA MOHAN plans to sell 13.69K shares of MERSANA THERAPEUTICS, INC. valued at approximately $27.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/7/2024ACC: 0001104659-24-106735
Officer· SVP, Chief Development Officer
Since Sep 2023
13.69K
Shares to sell
$27.6K
Approx. market value
50K
Acquired (3 months)
2
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit grant
Services rendered
10/1/2024
50KTotal acquired50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/1/2024 | Vesting of restricted stock unit grant Services rendered | 50K | — |
| Total | 50K | ||
Planned & Completed Dispositions2
NASDAQPlanned
Units to sell
5.60K
Market value
$11.3K
10/3/2024
NASDAQPlanned
Units to sell
8.09K
Market value
$16.3K
10/2/2024
Total
Units
13.69K
Value
$27.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/3/2024 | 5.60K | $11.3K | NASDAQ | Planned |
10/2/2024 | 8.09K | $16.3K | NASDAQ | Planned |
| Total | 13.69K | $27.6K | ||